Marc Robillard

Company: Tagworks Pharmaceuticals

Job title: Chief Scientific Officer

Bio:

Marc is co-founder and CSO of Tagworks, a pioneer of in vivo click chemistry, and the inventor of the now widely used Click-to-Release approach for improved systemic therapies. Marc worked at Philips Healthcare on molecular imaging and drug delivery programs, eventually focusing on in vivo click chemistry applications in these domains. Prior to Philips, he worked at Kreatech Diagnostics on the development of probes for drug targeting and microarray-based detection of DNA, RNA and proteins. In addition, he was a visiting scientist at the School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney.

Seminars:

ADCs x Radioligands: The Use of One Technology to Advance the Other 9:30 am

Discussing key learnings for both technologies to understand where they can lend value to each other  Convergence of targeting technologies between ADCs and Radio  Using linker technology from ADC to improve the rapid uptake and excretion profile of radioligands when separating target ligands from radioligand payloads in the tumor  Overcoming challenges associated with elimination, how do you get an ADC…Read more

day: Day One Red Track